Trials / Not Yet Recruiting
Not Yet RecruitingNCT05953402
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
ZEPOSIA® (Ozanimod) Ulcerative Colitis Pregnancy Registry: a Prospective, Observational Study on the Safety of Ozanimod Exposure in Pregnant Women With Ulcerative Colitis and Their Offspring
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,182 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate association between ozanimod exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
Conditions
Timeline
- Start date
- 2025-12-03
- Primary completion
- 2033-06-29
- Completion
- 2033-06-30
- First posted
- 2023-07-20
- Last updated
- 2025-12-03
Source: ClinicalTrials.gov record NCT05953402. Inclusion in this directory is not an endorsement.